Pharma Pricing & Reimbursement Conference, 21st-22nd of October 2013, London

Date: Aug-07-201319 Years of Success: European Pharmaceutical Pricing and Reimbursement:
Getting Ready for Value-Based Pricing.

Novartis, Eli Lilly & Co, Quintiles, Astra Zeneca, Imperial College London, White & Case will meet at SMi's 19th Annual Pharmaceutical Pricing & Reimbursement Conference in London.

Following on from its hugely successful conference in 2012, this year's Pharma Pricing & Reimbursement Conference, taking place on the 21st-22nd of October 2013 in London, UK, will feature over 16 thought-provoking presentations delivered by some of the leading names in the Pharma industry, discussing the Impact of HTA in different markets, value based pricing and future effects, healthcare reforms in Europe and how they are effecting P&R.
 
The conference will focus on European and US markets including country specific case studies proving strategic insight into how a wide range of complex issues can be readily adapted to. The event will provides the most comprehensive up to date centre of information with reimbursement evidence in product development and international based price referencing.

"The ever changing P&R environment in the UK throws up a smorgasbord of challenges and opportunities for pharma organisations"  National Commissioning Specialist, Genzyme.

Key Reasons to Attend:
Understand how value based pricing will affect the U.Ks pricing market and what to expect
Discuss key market access strategies with a range of case studies including those currently being developed successfully with orphan drugs
Evaluate current strategies with the new NICE network reforms
See the establishment of the pan-European HTA network and its current effects
Develop future cross sector market access strategies

Key Speakers Include:
Patrick Mollon, Director Global HE&OR Critical Care, Novartis
Anne-Toni Rodgers, Global Pricing and Market Access, AstraZeneca
Peter Hertzman, Director, Bristol Myers Squibb
Franz Pichler, Director, Global Public Policy, Eli Lilly & Co
Sarah Pitiluck, Senior Director, Global Pricing & Reimbursement, Alexion Pharma
Janice Haigh, Director Market Access, Quintiles

The conference will be followed by an interactive half-day workshop "HTA Uncovered" hosted by Janice Haigh, Practice Leader, Market Access, Europe, and Anke van Engen, Director Consulting, Quintiles.

For the full conference programme and further information please visit: 
www.smi-online.co.uk/2013europricing47.asp

Alternatively contact Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk

Sponsorship opportunities are available for this event, please contact Alia Malick on +44(0) 20 7827 6168 or email: amalick@smi-online.co.uk

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.